Shanghai MicroPort MedBot (Group) Co., Ltd. (MedBot, HKEX: 02252) has filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming that both authorised and issued share capital remained unchanged during the month.

Total authorised share capital stayed at RMB 1.03 billion, comprising 1.03 billion H shares and 609,745 domestic shares, each with a par value of RMB 1. The issued share count was also steady at 1.03 billion H shares and 609,745 domestic shares. MedBot held no treasury shares at month-end and reported zero share issuances, cancellations, or repurchases in May.

The company’s 2022 Share Option Scheme shows no outstanding options and no exercises during the month. Up to 95.20 million H shares remain available for potential future grants, but none were issued in May. No warrants, convertible securities, or other equity-linked instruments were outstanding or exercised.

MedBot affirmed compliance with Hong Kong Stock Exchange public-float requirements, maintaining at least 25% of H shares in public hands. The monthly return was submitted on 3 June 2026 by Company Secretary Yeung Siu Lam.